Intelligence · Clinical Development
Pipeline search results
Programs matching “acute-myeloid-leukemia” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 134 pipeline programs matching "acute-myeloid-leukemia" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
CT053PTSA
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acute Myeloid Leukemia (AML)
1 trial -
CVA
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
Clifutinib Besylate
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acute Myeloid Leukemia
1 trial -
Clifutinib with fed state
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acute Myeloid Leukemia in Children
1 trial -
Decitabine
Foghorn Therapeutics
Acute Myeloid Leukemia
1 trial -
Dociparstat sodium
BRIGHT MINDS BIOSCIENCES INC.
Acute Myeloid Leukemia
1 trial -
FT538
Zafatek
Acute Myeloid Leukemia
1 trial -
Gilteritinib
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia With FLT3/ITD Mutation
1 trial -
HMPL-306
Hutchison Medipharma Limited
Acute Myeloid Leukemia
1 trial -
IBR733 Cell Injection
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
IIT2025079
Xiyuan Hospital of China Academy of Chinese Medical Sciences
AML - Acute Myeloid Leukemia
1 trial -
IRX5183
IO Biotech
Acute Myeloid Leukemia (AML)
1 trial -
KPT-9274
Karyopharm Therapeutics Inc
Acute Myeloid Leukemia
1 trial -
LCAR-AMDR Cells Product
Nanjing Legend Biotech Co.
Acute Myeloid Leukemia
1 trial -
MT-401-OTS
Marker Therapeutics
Acute Myeloid Leukemia, in Relapse
1 trial -
ODSH
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial -
Olutasidenib Investigational Agent Administration
RIGEL PHARMACEUTICALS INC
Acute Myeloid Leukemia
1 trial -
PRT1419
Prelude Therapeutics Inc
Acute Myeloid Leukemia
1 trial -
Pitavastatin
United Therapeutics Europe Ltd
Acute Myeloid Leukemia
1 trial -
Revumenib
Syndax Pharmaceuticals
Refractory Acute Myeloid Leukemia
1 trial -
SC-DARIC33
Regeneron UK Limited
Acute Myeloid Leukemia
1 trial -
SNDX-5613
Syndax Pharmaceuticals
Acute Myeloid Leukemias
1 trial -
Venetoclax
Kura Oncology
Acute Myeloid Leukemia
1 trial -
Vyxeos
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.